Literature DB >> 6358135

Mohs surgery: techniques, indications, and applications in head and neck surgery.

N A Swanson, R C Grekin, S R Baker.   

Abstract

Mohs surgery, as it has evolved since its inception by Dr. Mohs, is a technique for removal of certain cancers using careful, precise microscopic marginal control. The contemporary technique using fresh tissue is detailed, illustrating advantages that include maximal conservation of normal surrounding tissue and structures, an extremely high cure rate, and a tumor-free defect which can be reconstructed immediately. The indications and applications for Mohs surgery, once limited to large recurrent basal cell carcinomas, have expanded to include several cutaneous and paracutaneous neoplasms. These, with an emphasis on certain basal cell carcinomas, are discussed in detail. With better understanding of the Mohs technique, its indications, applications, and advantages, an interdisciplinary approach to certain cutaneous and paracutaneous neoplasms is proposed.

Entities:  

Mesh:

Year:  1983        PMID: 6358135     DOI: 10.1002/hed.2890060209

Source DB:  PubMed          Journal:  Head Neck Surg        ISSN: 0148-6403


  7 in total

1.  Mohs micrographic surgery histopathology concordance.

Authors:  Kavita Mariwalla; Sumaira Z Aasi; Earl J Glusac; David J Leffell
Journal:  J Am Acad Dermatol       Date:  2009-01       Impact factor: 11.527

2.  Recurrence after treatment of nonmelanoma skin cancer: a prospective cohort study.

Authors:  Mary-Margaret Chren; Jeanette S Torres; Sarah E Stuart; Daniel Bertenthal; Remedios J Labrador; W John Boscardin
Journal:  Arch Dermatol       Date:  2011-05

3.  Mohs' micrographic surgery of the head and neck.

Authors:  G L Darmstadt; H K Steinman
Journal:  West J Med       Date:  1990-02

4.  A reliable frozen section technique for basal cell carcinomas of the head and neck.

Authors:  Wisam Menesi; Edward W Buchel; Thomas Je Hayakawa
Journal:  Plast Surg (Oakv)       Date:  2014       Impact factor: 0.947

5.  Patient satisfaction after treatment of nonmelanoma skin cancer.

Authors:  Maryam M Asgari; Daniel Bertenthal; Saunak Sen; Anju Sahay; Mary-Margaret Chren
Journal:  Dermatol Surg       Date:  2009-05-08       Impact factor: 3.398

6.  Treatment of nonfatal conditions at the end of life: nonmelanoma skin cancer.

Authors:  Eleni Linos; Rupa Parvataneni; Sarah E Stuart; W John Boscardin; C Seth Landefeld; Mary-Margaret Chren
Journal:  JAMA Intern Med       Date:  2013-06-10       Impact factor: 21.873

7.  Tumor recurrence 5 years after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma.

Authors:  Mary-Margaret Chren; Eleni Linos; Jeanette S Torres; Sarah E Stuart; Rupa Parvataneni; W John Boscardin
Journal:  J Invest Dermatol       Date:  2012-11-29       Impact factor: 8.551

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.